Haplotype Labs
YC W24 ↗San Francisco, US · Founded 2024 · 1 employees · 2 known investors
Haplotype Labs develops population genetics software and polygenic risk scores with improved security, accessibility, and sophistication to enhance human healthspan. The company serves researchers, healthcare providers, and consumers seeking genetic risk assessment tools.
AI & Machine LearningBiotechHealthtechMedical DevicesSaaSin /haplotype-labs/@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (W24)
MP
Mike PolcariinFounder
MP
Michael PolcariExecutive Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$1.1MraisedApr 2024 · 5 investors · Other TechnologyRule 506(b)
▶$1.1MraisedApr 2024 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael PolcariExecutive Officer
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Minimum investment
- $50K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 04, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Haplotype Labs - Personalized prevention using genetics and AIycombinator.com · 2024
- Haplotype Labs Funding | Complete Analysis | Extruct AIextruct.ai · 2024
